相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atmospheric fine particulate matter exposure exacerbates atherosclerosis in apolipoprotein E knockout mice by inhibiting autophagy in macrophages via the PI3K/Akt/mTOR signaling pathway
Qiang Wan et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2021)
miR-654-5p inhibits autophagy by targeting ATG7 via mTOR signaling in intervertebral disc degeneration
Shanzheng Wang et al.
MOLECULAR MEDICINE REPORTS (2021)
Rapamycin-Loaded Polymeric Nanoparticles as an Advanced Formulation for Macrophage Targeting in Atherosclerosis
Emanuela Fabiola Craparo et al.
PHARMACEUTICS (2021)
Combined application of rapamycin and atorvastatin improves lipid metabolism in apolipoprotein E-deficient mice with chronic kidney disease
Eun Ju Song et al.
BMB REPORTS (2021)
Silencing of RHEB inhibits cell proliferation and promotes apoptosis in colorectal cancer cells via inhibition of the mTOR signaling pathway
Yuxi Tian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling
Yuhu He et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Activation of AMPK/proteasome/MLCK degradation signaling axis by telmisartan inhibits VSMC contractility and vessel contraction
Yun-Jin Hwang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway (Publication with Expression of Concern. See vol. 21, pg. 881, 2022)
Rong Huang et al.
CELL CYCLE (2020)
NLRC3 inhibits PDGF-induced PASMCs proliferation via PI3K-mTOR pathway
Li-huang Zha et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
BI6727, a polo-like kinase 1 inhibitor with promising efficacy on Burkitt lymphoma cells
Er Chen et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Piceatannol Suppresses the Proliferation and Induced Apoptosis of Osteosarcoma Cells Through PI3K/AKT/mTOR Pathway
Bin Wang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2
Ye Fan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Downregulation of the GLP-1/CREB/adiponectin pathway is partially responsible for diabetes -induced dysregulated vascular tone and VSMC dysfunction
Xiaowei Xiong et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Rapamycin Induces an eNOS (Endothelial Nitric Oxide Synthase) Dependent Increase in Brain Collateral Perfusion in Wistar and Spontaneously Hypertensive Rats
Daniel J. Beard et al.
STROKE (2020)
Newcastle Disease virus infection activates PI3K/Akt/mTOR and p38 MAPK/Mnk1 pathways to benefit viral mRNA translation via interaction of the viral NP protein and host eIF4E
Yuan Zhan et al.
PLOS PATHOGENS (2020)
Ras, PI3K and mTORC2 three's a crowd?
Stephen F. Smith et al.
JOURNAL OF CELL SCIENCE (2020)
Stimulatory effect of insulin on H+-ATPase in the proximal tubule via the Akt/mTORC2 pathway
M. Nakamura et al.
PHYSIOLOGY INTERNATIONAL (2020)
Efficient Treatment of Atherosclerosis by Dexamethasone Acetate and Rapamycin Co-Loaded mPEG-DSPE Calcium Phosphate Nanoparticles
Xianghong Luo et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2020)
Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model
Juan Zhang et al.
FASEB JOURNAL (2020)
Long noncoding RNA ZNF800 suppresses proliferation and migration of vascular smooth muscle cells by upregulating PTEN and inhibiting AKT/mTOR/HIF-1α signaling
Yuan-Bin Lu et al.
ATHEROSCLEROSIS (2020)
Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis
Yun-Jin Hwang et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathway
Minghao Zhang et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2020)
Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
Zhenru Xu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE(-/-)) mice
Yanan Song et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Sin1/mTORC2 regulate B cell growth and metabolism by activating mTORC1 and Myc
Man Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson's Disease
Zhou Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer
M. L. Alabdullah et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2019)
mTORC1 is required for expression of LRPPRC and cytochrome-c oxidase but not HIF-1α in Leigh syndrome French Canadian type patient fibroblasts
Yvette Mukaneza et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
Disruption of the Scaffolding Function of mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2-Dependent Tumor Growth In Vivo
Yoonha Hwang et al.
CANCER RESEARCH (2019)
Wild-type p53-induced phosphatase 1 promotes vascular smooth muscle cell proliferation and neointima hyperplasia after vascular injury via p-adenosine 50′-monophosphate-activatedprotein kinase/mammalian target of rapamycin complex 1 pathway
Xiongshan Sun et al.
JOURNAL OF HYPERTENSION (2019)
Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells (vol 205, pg 126, 2009)
Paula M. Brito et al.
ATHEROSCLEROSIS (2019)
Cardiomyocyte targeted overexpression of IGF1 during detraining restores compromised cardiac condition via mTORC2 mediated switching of PKCδ to PKCα
Emeli Chatterjee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR
Yingshuai Zhao et al.
CARDIOLOGY (2019)
Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor/phosphatidylinositol-3-kinase signaling pathway
Yu-ting Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
Ali S. Alzahrani
SEMINARS IN CANCER BIOLOGY (2019)
Shen-Yuan-Dan Capsule Attenuates Atherosclerosis and Foam Cell Formation by Enhancing Autophagy and Inhibiting the PI3K/Akt/mTORC1 Signaling Pathway
Mingxue Zhou et al.
FRONTIERS IN PHARMACOLOGY (2019)
Hypothalamic mTORC2 is essential for metabolic health and longevity
Karthikeyani Chellappa et al.
AGING CELL (2019)
Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer
Sandeep Kumar et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
miR-92b-3p-TSC1 axis is critical for mTOR signaling-mediated vascular smooth muscle cell proliferation induced by hypoxia
Jihui Lee et al.
CELL DEATH AND DIFFERENTIATION (2019)
Therapeutic Suppression of mTOR (Mammalian Target of Rapamycin) Signaling Prevents and Reverses Salt-Induced Hypertension and Kidney Injury in Dahl Salt-Sensitive Rats
Vikash Kumar et al.
HYPERTENSION (2019)
Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer
Fatima Mohsen Mroueh et al.
FASEB JOURNAL (2019)
mTOR as a central hub of nutrient signalling and cell growth
Joungmok Kim et al.
NATURE CELL BIOLOGY (2019)
mTORC1 and mTORC2 Differentially Regulate Cell Fate Programs to Coordinate Osteoblastic Differentiation in Mesenchymal Stromal Cells
Theres Schaub et al.
SCIENTIFIC REPORTS (2019)
Nesfatin-1 functions as a switch for phenotype transformation and proliferation of VSMCs in hypertensive vascular remodeling
Qing-Bo Lu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Vascular smooth muscle cell proliferation as a therapeutic target. Part 2: Natural products inhibiting proliferation
Pavel Uhrin et al.
BIOTECHNOLOGY ADVANCES (2018)
Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis
Mandy O. J. Grootaert et al.
CARDIOVASCULAR RESEARCH (2018)
Nitrite exerts antioxidant effects, inhibits the mTOR pathway and reverses hypertension-induced cardiac hypertrophy
Danielle A. Guimaraes et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Rapamycin Alleviates Hormone Imbalance-Induced Chronic Nonbacterial Inflammation in Rat Prostate Through Activating Autophagy via the mTOR/ULK1/ATG13 Signaling Pathway
Yang Su et al.
INFLAMMATION (2018)
Micheliolide alleviates hepatic steatosis in db/db mice by inhibiting inflammation and promoting autophagy via PPAR-γ-mediated NF-κB and AMPK/mTOR signaling
Juan Zhong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Mammalian target of rapamycin inhibition attenuates myocardial ischaemia-reperfusion injury in hypertrophic heart
Lei-Lei Ma et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Dual mTOR/PI3K inhibition limits PI3K-dependent pathways activated upon mTOR inhibition in autosomal dominant polycystic kidney disease
Yang Liu et al.
SCIENTIFIC REPORTS (2018)
The Anti-atherosclerotic Effect of Paeonol against Vascular Smooth Muscle Cell Proliferation by Up-regulation of Autophagy via the AMPK/mTOR Signaling Pathway
Hongfei Wu et al.
FRONTIERS IN PHARMACOLOGY (2018)
Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NF kappa B/mTOR/P70S6K signaling cascade
Qing-Bo Lu et al.
REDOX BIOLOGY (2018)
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis
Chadi Zakaria et al.
PLOS PATHOGENS (2018)
Rapamycin inhibits ox-LDL-induced inflammation in human endothelial cells in vitro by inhibiting the mTORC2/PKC/c-Fos pathway
Juan-juan Sun et al.
ACTA PHARMACOLOGICA SINICA (2018)
Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease
Ai-Ling Lin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
mTORC1 and mTORC2 as regulators of cell metabolism in immunity
Monika Linke et al.
FEBS LETTERS (2017)
Inhibition of Mammalian Target of Rapamycin Complex 1 Attenuates Salt-Induced Hypertension and Kidney Injury in Dahl Salt-Sensitive Rats
Vikash Kumar et al.
HYPERTENSION (2017)
Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension
Victor Segura-Ibarra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Localization of mTORC2 activity inside cells
Michael Ebner et al.
JOURNAL OF CELL BIOLOGY (2017)
Moderate Autophagy Inhibits Vascular Smooth Muscle Cell Senescence to Stabilize Progressed Atherosclerotic Plaque via the mTORC1/ULK1/ATG13 Signal Pathway
Zhenli Luo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
mTOR-Notch3 signaling mediates pulmonary hypertension in hypoxia-exposed neonatal rats independent of changes in autophagy
Julijana Ivanovska et al.
PEDIATRIC PULMONOLOGY (2017)
Twenty-five years of mTOR: Uncovering the link from nutrients to growth
David M. Sabatini
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling
Mee-Sup Yoon
NUTRIENTS (2017)
Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development
Pin Liu et al.
ONCOTARGET (2017)
Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model
Xiaofan Ma et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2017)
Kaempferol alleviates ox-LDL-induced apoptosis by up-regulation of autophagy via inhibiting PI3K/Akt/mTOR pathway in human endothelial cells
Jianbo Che et al.
CARDIOVASCULAR PATHOLOGY (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex
Jessica J. Howell et al.
CELL METABOLISM (2017)
Systemic rapamycin to prevent in-stent stenosis in peripheral pulmonary arterial disease: early clinical experience
Anna Hallbergson et al.
CARDIOLOGY IN THE YOUNG (2016)
HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension
Tatiana V. Kudryashova et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
MicroRNA-761 inhibits Angiotensin II-induced vascular smooth muscle cell proliferation and migration by targeting mammalian target of rapamycin
Jung Rae Cho et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2016)
Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation
Min-Jung Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs
Pan Tan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
mTORC2 Puts Its Shoulder to Krebs' Wheel
Sebastian I. Arriola Apelo et al.
MOLECULAR CELL (2016)
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Vanessa S. Rodrik-Outmezguine et al.
NATURE (2016)
Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway
Yunyang Chen et al.
PLOS ONE (2016)
Perfluorooctanoic acid induces human Ishikawa endometrial cancer cell migration and invasion through activation of ERK/mTOR signaling
Zhinan Ma et al.
ONCOTARGET (2016)
Vascular smooth muscle cell in atherosclerosis
D. A. Chistiakov et al.
ACTA PHYSIOLOGICA (2015)
A Novel Quinoline Based Second-generation mTOR Inhibitor that Induces Apoptosis and Disrupts PI3K-Akt-mTOR Signaling in Human Leukemia HL-60 Cells
Suresh Kumar et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1
Jung Min Ha et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways
Lili Shi et al.
CARDIOVASCULAR DIABETOLOGY (2015)
mTOR kinase inhibitor pp242 causes mitophagy terminated by apoptotic cell death in E1A-Ras transformed cells
Serguei A. Gordeev et al.
ONCOTARGET (2015)
MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent In Vitro and In Vivo Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma
Emily K. Slotkin et al.
MOLECULAR CANCER THERAPEUTICS (2015)
A Critical Role of the mTOR/eIF2α Pathway in Hypoxia-Induced Pulmonary Hypertension
Ai-ping Wang et al.
PLOS ONE (2015)
mTOR inhibition: A promising strategy for stabilization of atherosclerotic plaques
Wim Martinet et al.
ATHEROSCLEROSIS (2014)
Mammalian Target of Rapamycin Complex 2 ( mTORC2) Coordinates Pulmonary Artery Smooth Muscle Cell Metabolism, Proliferation, and Survival in Pulmonary Arterial Hypertension
Dmitry A. Goncharov et al.
CIRCULATION (2014)
Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR
Song Lin et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2014)
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Mitsugu Shimobayashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2
Weijie Wang et al.
PLOS ONE (2014)
Growing knowledge of the mTOR signaling network
Kezhen Huang et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E-/- mice
Nan Peng et al.
SCIENTIFIC REPORTS (2014)
Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension
Amal Houssaini et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects
Elena A. Goncharova
FASEB JOURNAL (2013)
Dual mTORC1 and mTORC2 inhibitor Palomid 529 penetrates the Blood-Brain Barrier without restriction by ABCB1 and ABCG2
Fan Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Demethoxycurcumin, a major active curcuminoid from Curcuma longa, suppresses balloon injury induced vascular smooth muscle cell migration and neointima formation: An in vitro and in vivo study
Ming-Jyh Sheu et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Signal integration by mTORC1 coordinates nutrient input with biosynthetic output
Christian C. Dibble et al.
NATURE CELL BIOLOGY (2013)
被撤回的出版物: Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines (Retracted article. See vol. 13, art. e0202299, 2018)
Su-Lin Lee et al.
PLOS ONE (2013)
Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial
Hans-Juergen Seyfarth et al.
PULMONARY CIRCULATION (2013)
Reconstitution of leucine-mediated autophagy via the mTORC1-Barkor pathway in vitro
Xianghua Yan et al.
AUTOPHAGY (2012)
Activation of mTORC2 by Association with the Ribosome
Vittoria Zinzalla et al.
CELL (2011)
Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
Jessica L. Yecies et al.
CELL METABOLISM (2011)
Rictor/mTORC2 Is Essential for Maintaining a Balance Between β-Cell Proliferation and Cell Size
Yanyun Gu et al.
DIABETES (2011)
mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia
Vera P. Krymskaya et al.
FASEB JOURNAL (2011)
Distinct patterns of autophagy evoked by two benzoxazine derivatives in vascular endothelial cells
Li Wang et al.
AUTOPHAGY (2010)
Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
Yasemin Sancak et al.
CELL (2010)
The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma (Publication with Expression of Concern. See vol. 25, pg. 4194, 2019)
Daniel C. Cho et al.
CLINICAL CANCER RESEARCH (2010)
RhoA and Rho Kinase Activation in Human Pulmonary Hypertension Role of 5-HT Signaling
Christophe Guilluy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
ULK1•ATG13•FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy
Ian G. Ganley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
Nicholas W. Morrell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Signaling Pathways Regulating Vascular Smooth Muscle Cell Differentiation
Eva M. Rzucidlo
VASCULAR (2009)
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman et al.
NATURE MEDICINE (2008)
(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms
Florian Lang et al.
PHYSIOLOGICAL REVIEWS (2006)
Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice - Inhibitory effect on monocyte chemotaxis
R Pakala et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 (Kip1)-independent pathway
C Castro et al.
ATHEROSCLEROSIS (2004)
MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
DH Kim et al.
CELL (2002)
分享论文
